| 영문 | plasma | 한글 | 혈장 |
|---|---|---|---|
| 설명 | 혈액이나 림프액의 액체 부분을 말하는데, 주로 혈액에서 고형성분(혈구세포)을 제외한 액체 부분을 의미한다. 여기에는 단백성분(면역현상을 유발하는 항체를 포함함), 영양성분(각 세포에 영양분을 공급함), 그리고 혈액응고 성분(상처가 났을 때 출혈이 멎을 수 있도록 함) 등이 포함된다. |
||
| 영문 | plasma membrane | 한글 | 형질막 |
|---|---|---|---|
| 설명 | 원형질 표면을 덮는 엷은막. 두께는 5~25μm이다. 광학현미경으로는 관찰할 수 없지만 전자현미경으로 관찰이 가능하다. 원형질막의 분자구조는 레시틴이나 콜레스테롤 등의 표면 활성물질 분자가 2분자층으로 그 표면에 배열되며, 이것을 각 1분자층의 단백질 분자가 양쪽에서 샌드위치한 단위막 구조이다. 전자현미경적으로 이 단위는 암-명-암의 3층(각 약 20nm)으로 구별된다. 원형질의 투과성에 중요한 구실을 하며, 생리상태가 변하면 그 투과성도 신속히 변한다. 또, 손상이 되면 쉽게 새로 형성된다. |
||
| PTA | parallel tubular arrays; parathyroid adenoma; percutaneous transluminal angioplasty; peroxidase-labe... |
|---|---|
| PTA | 1) Prior To Admission 2) Plasma Thromboplatin Antecedent |
| PTC | 1) Percutaneous Transhepatic Cholangiography = PTHC ... |
| PT | pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t... |
| PTC | papillary thyroid carcinoma; percutaneous transhepatic cholangiography; phase transfer catalyst; phe... |
| APTT | Activated Partial Thromboplastin Time |
|---|---|
| APTT | Activated partial thromboplastin |
| aPTT | Partial thromboplastin time |
| TP | thromboplastin |
| PRP | 1--Platelet-rich plasma |
| plasma thromboplastin antecedent | <chemical> Stable blood coagulation factor involved in the intrinsic pathway. The activated form xia activates factor ix to ixa. Deficiency of factor xi is often called haemophilia c. Chemical name: Blood-coagulation factor XI (12 Dec 1998) |
|---|
| plasma thromboplastin component | <chemical> Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, ixa, forms a complex with factor viii and calcium on platelet factor 3 to activate factor x to xa. Deficiency of factor ix results in christmas disease (haemophilia b). Chemical name: Blood-coagulation factor IX (12 Dec 1998) |
|---|---|
| plasma thromboplastin factor | A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs. (12 Dec 1998) |
| plasma thromboplastin factor B | <chemical> Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, ixa, forms a complex with factor viii and calcium on platelet factor 3 to activate factor x to xa. Deficiency of factor ix results in christmas disease (haemophilia b). Chemical name: Blood-coagulation factor IX (12 Dec 1998) |
| antecedent | Existing or occurring before in time or order often with consequential effects. (18 Nov 1997) |
| antecedent sign | <clinical sign> A sign that appears during the prodrome of a disease. Synonym: antecedent sign. (05 Mar 2000) |
| activated partial thromboplastin time | The time needed for plasma to form a fibrin clot following the addition of calcium and a phospholipid reagent; used to evaluate the intrinsic clotting system. (05 Mar 2000) |
| partial thromboplastin time | Test of the intrinsic (factors viii, ix, xi, and xii) and common (fibrinogen, prothrombin, factors v and x) pathways of coagulation in which a mixture of plasma and phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides) is recalcified and the time required for the appearance of fibrin strands measured. Activation may be provided by contact with the glass tube or exposure to activators (e.g., ellagic acid, particulate silicates such as diatomaceous earth or kaolin) before addition of the calcium chloride. It is used as a screening test and to monitor heparin therapy. (12 Dec 1998) |
| thromboplastin | <haematology> Traditional name for substance in plasma that converts prothrombin to thrombin. Now known not to be a single substance. (See thrombin). (18 Nov 1997) |
| tissue thromboplastin inhibition time | A test used to identify lupus anticoagulant; the thromboplastin source used in the prothrombin test is diluted to increase sensitivity to inhibitors. (05 Mar 2000) |
| antihemophilic plasma | Human plasma in which the labile antihemophilic globulin component, present in fresh plasma, has been preserved; it is used to temporarily relieve dysfunction of the haemostatic mechanism in haemophilia. (05 Mar 2000) |
| apical plasma membrane | <cell biology> The term used for the cell membrane on the apical (inner or upper) surface of transporting epithelial cells. This region of the cell membrane is separated, in vertebrates, from the baso lateral membrane by a ring of tight junctions that prevents free mixing of membrane proteins from these two domains. (18 Nov 1997) |
| basolateral plasma membrane | <cell biology> The plasma membrane of epithelial cells that is adjacent to the basal lamina or the adjoining cells of the sheet. Differs both in protein and phospholipid composition from the apical plasma membrane from which it is isolated by tight junctions (zonula occludentes). (18 Nov 1997) |
| beam-plasma reaction | <radiobiology> Fusion reaction which occurs from the collision of a fast beam ion with a thermal plasma ion. (09 Oct 1997) |
| bean-shaped plasma | <radiobiology> A toroidal plasma indented on the inboard side (the side with the donut hole), that results in additional stability to ballooning modes. Moderate indentation may provide access to the second-stability region (high beta). (13 Nov 1997) |
| blood plasma | <haematology> Acellular fluid in which blood cells are suspended. Serum obtained by defibrinating plasma (plasma derived serum) lacks platelet released factors and is less suitable to support the growth of cells in culture. (13 Oct 1997) |
| plasma thromboplastin antecedent |
coagulation factor whose deficiency results in a hemorrhagic tendency
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| plasma thromboplastin antecedent d. |
hemophilia C.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| plasma thromboplastin antecedent | coagulation factor whose deficiency results in a hemorrhagic tendency |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|